Capsaicin evokes hypothermia independent of cannabinoid CB1 and CB2 receptors

Brain Research

Volumn 1065, Issue 1-2, 2005, Pages 147-151

  Ding, Zhe ^a   Cowan, Alan ^a   Rawls, Scott M ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cannabinoid; Capsaicin; Hypothermia; SB 366791; SR 141716A; Vanilloid; WIN 55212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CAPSAICIN; CAPSAZEPINE; RIMONABANT; VANILLOID RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DRUG EFFECT; HYPOTHERMIA; MALE; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL; RAT;

ANILIDES; ANIMALS; BODY TEMPERATURE; BORNANES; CALCIUM CHANNEL BLOCKERS; CAPSAICIN; CINNAMATES; HYPOTHERMIA; MALE; MORPHOLINES; NAPHTHALENES; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; TRPV CATION CHANNELS;

ANIMALIA;

EID: 28844502719     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.10.026     Document Type: Article

References (28)

1. F.M. Casiano, R. Arnold, D. Haycock, J. Kuster, and S.J. Ward Title:Putative aminoalkylindoles (AAI) antagonists NIDA Res. Monogr. 105 1991 295 296
2. M.J. Caterina, M.A. Schumacher, M. Tominaga, T.A. Rosen, J.D. Levine, and D. Julius The capsaicin receptor: a heat-activated ion channel in the pain pathway Nature 389 1997 816 824
3. D.R. Compton, L.H. Gold, S.J. Ward, R.L. Balster, and B.R. Martin Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol J. Pharmacol. Exp. Ther. 263 1992 1118 1126
4. B. Costa, G. Giagnoni, C. Franke, A.E. Trovato, and M. Colleoni Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation Br. J. Pharmacol. 143 2004 247 250
5. V. Di Marzo, C. Breivogel, T. Bisogno, D. Melck, G. Patrick, Q. Tao, A. Szallasi, R.K. Razdan, and B.R. Martin Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide Eur. J. Pharmacol. 406 2000 363 374
6. M.D. Dogan, S. Patel, A.Y. Rudaya, A.A. Steiner, M. Szekely, and A.A. Romanovsky Lipopolysaccharide fever is initiated via a capsaicin-sensitive mechanism independent of the subtype-1 vanilloid receptor Br. J. Pharmacol. 143 2004 1023 1032
7. A. Fox, A. Kesingland, C. Gentry, K. McNair, S. Patel, L. Urban, and I. James The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain Pain 92 2001 91 100
8. 1 cannabinoid receptor-dependent modulation of feeding J. Neurosci. 22 2002 9612 9617
9. M.J. Gunthorpe, H.K. Rami, J.C. Jerman, D. Smart, C.H. Gill, E.M. Soffin, S. Luis Hannan, S.C. Lappin, J. Egerton, G.D. Smith, A. Worby, L. Howett, D. Owen, S. Nasir, C.H. Davies, M. Thompson, P.A. Wyman, A.D. Randall, and J.B. Davis Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist Neuropharmacology 46 2004 133 149
10. M. Hajos, S. Hjorth, and A. Carlsson Injection of capsaicin into the nucleus raphe dorsalis elicits heat loss in the rat Neurosci. Lett. 75 1987 199 204
11. A.G. Hohmann, J.N. Farthing, A.M. Zvonok, and A. Makriyannis Selective activation of cannabinoid CB2 receptors suppresses hyperalgesia evoked by intradermal capsaicin J. Pharmacol. Exp. Ther. 308 2004 446 453
12. L.M. Johanek, D.R. Heitmiller, M. Turner, N. Nader, J. Hodges, and D.A. Simone Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms Pain 93 2001 303 315
13. J. Li, R.S. Daughters, C. Bullis, R. Bengiamin, M.W. Stucky, J. Brennan, and D.A. Simone The cannabinoid receptor agonist WIN 55,212-2 mesylate blocks the development of hyperalgesia produced by capsaicin in rats Pain 81 1999 25 33
14. D.T. Malone, and D.A. Taylor Modulation of delta9-tetrahydrocannabinol- induced hypothermia by fluoxetine in the rat Br. J. Pharmacol. 124 1998 1419 1424
15. B.R. Martin, D.R. Compton, B.F. Thomas, W.R. Prescott, P.J. Little, R.K. Razdan, M.R. Johnson, L.S. Melvin, R. Mechoulam, and S.J. Ward Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs Pharmacol. Biochem. Behav. 40 1991 471 478
16. M.S. Miller, K. Brendel, S.H. Buck, and T.F. Burks Dihydrocapsaicin- induced hypothermia and substance P depletion Eur. J. Pharmacol. 83 1982 289 292
17. F. Nava, G. Carta, and G.L. Gessa Permissive role of dopamine D(2) receptors in the hypothermia induced by delta(9)-tetrahydrocannabinol in rats Pharmacol. Biochem. Behav. 66 2000 183 187
18. A. Quartilho, H.P. Mata, M.M. Ibrahim, T.W. Vanderah, F. Porreca, A. Makriyannis, and T.P. Malan Jr. Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors Anesthesiology 99 2003 955 960
19. H.K. Rami, M. Thompson, P. Wyman, J.C. Jerman, J. Egerton, S. Brough, A.J. Stevens, A.D. Randall, D. Smart, M.J. Gunthorpe, and J.B. Davis Discovery of small molecule antagonists of TRPV1 Bioorg. Med. Chem. Lett. 14 2004 3631 3634
20. S.M. Rawls, A. Cowan, R.J. Tallarida, E.B. Geller, and M.W. Adler N-methyl-d-aspartate antagonists and WIN 55212-2[4,5-dihydro-2-methyl-4(4- morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i,j] quinolin-6-one], a cannabinoid agonist, interact to produce synergistic hypothermia J. Pharmacol. Exp. Ther. 303 2002 395 402
21. S.M. Rawls, R.J. Tallarida, A.M. Gray, E.B. Geller, and M.W. Adler l-NAME (N omega-nitro-l-arginine methyl ester), a nitric-oxide synthase inhibitor, and WIN 55212-2[4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl- carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one], a cannabinoid agonist, interact to evoke synergistic hypothermia J. Pharmacol. Exp. Ther. 308 2004 780 786
22. J.D. Richardson, S. Kilo, and K.M. Hargreaves Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors Pain 75 1998 111 119
23. M. Rinaldi-Carmona, F. Barth, M. Heaulme, D. Shire, B. Calandra, C. Congy, S. Martinez, J. Maruani, G. Neliat, and D. Caput SR141716A, a potent and selective antagonist of the brain cannabinoid receptor FEBS Lett. 350 1994 240 244
24. M. Rinaldi-Carmona, F. Barth, J. Millan, J.M. Derocq, P. Casellas, C. Congy, D. Oustric, M. Sarran, M. Bouaboula, B. Calandra, M. Portier, D. Shire, J.C. Breliere, and G.L. Le Fur SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor J. Pharmacol. Exp. Ther. 284 1998 644 650
25. R. Rukwied, A. Watkinson, F. McGlone, and M. Dvorak Cannabinoid agonists attenuate capsaicin-induced responses in human skin Pain 102 2003 283 288
26. D.A. Taylor, and M.R. Fennessy Biphasic nature of the effects of delta9-tetrahydrocannabinol on body temperature and brain amines of the rat Eur. J. Pharmacol. 46 1977 93 99
27. A. Varga, J. Nemeth, A. Szabo, J.J. McDougall, C. Zhang, K. Elekes, E. Pinter, J. Szolcsanyi, and Z. Helyes Effects of the novel TRPV1 receptor antagonist SB366791 in vitro and in vivo in the rat Neurosci. Lett. 385 2005 137 142
28. S. Yoshihara, H. Morimoto, M. Ohori, Y. Yamada, T. Abe, and O. Arisaka The cannabinoid receptor agonist WIN 55212-2 inhibits neurogenic inflammations in airway tissues J. Pharmacol. Sci. 98 2005 77 82